Orchard Therapeutics plc (ORTX)
Jan 24, 2024 - ORTX was delisted (reason: acquired by Kyowa Kirin)
16.70
0.00 (0.00%)
Inactive · Last trade price on Jan 23, 2024
Orchard Therapeutics Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|---|
Period Ending | Sep '23 Sep 30, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | Dec '18 Dec 31, 2018 |
Cash & Equivalents | 23.47 | 68.42 | 55.91 | 55.14 | 19.05 | 335.84 |
Short-Term Investments | 101.94 | 75.33 | 164.2 | 136.81 | 305.94 | - |
Cash & Short-Term Investments | 125.41 | 143.75 | 220.11 | 191.95 | 324.99 | 335.84 |
Cash Growth | -14.42% | -34.69% | 14.67% | -40.94% | -3.23% | 273.76% |
Accounts Receivable | 6.19 | 8.47 | 1.48 | 0.88 | 1.44 | 2.1 |
Other Receivables | 10.79 | 8.87 | 35.24 | 22.14 | 19.54 | 10.59 |
Receivables | 16.97 | 17.34 | 36.72 | 23.02 | 20.99 | 12.69 |
Inventory | 6.64 | 3.4 | 2.02 | 0.67 | - | - |
Prepaid Expenses | 4 | 2.7 | 8.57 | 6.35 | 3.92 | 6.99 |
Other Current Assets | 0.9 | 0.96 | 7.91 | 1.55 | - | - |
Total Current Assets | 153.92 | 168.15 | 275.32 | 223.54 | 349.9 | 355.52 |
Property, Plant & Equipment | 27.13 | 30.91 | 29.08 | 34.6 | 27.01 | 5.48 |
Other Intangible Assets | 3.32 | 3.56 | 4.15 | 3.08 | - | - |
Long-Term Deferred Tax Assets | - | 7.37 | 4.09 | 5.22 | 2.99 | - |
Long-Term Deferred Charges | - | 0.46 | 0.69 | 0.98 | 0.31 | - |
Other Long-Term Assets | 17.89 | 8.46 | 9.08 | 13.54 | 19.08 | 5.05 |
Total Assets | 202.27 | 218.91 | 322.41 | 280.94 | 399.28 | 366.04 |
Accounts Payable | 3.66 | 9.32 | 10.01 | 8.82 | 11.98 | 18.13 |
Accrued Expenses | 30 | 30.67 | 21.59 | 25.78 | 34.99 | 24.06 |
Current Portion of Long-Term Debt | 9.43 | 9.43 | 0.79 | 4.86 | - | - |
Current Portion of Leases | 5.55 | 6.42 | 7.34 | 8.93 | 5.89 | - |
Current Unearned Revenue | 0.74 | 0.96 | 0.35 | - | - | - |
Other Current Liabilities | - | 3.77 | 2.73 | 3.17 | 2.99 | 5.72 |
Total Current Liabilities | 49.38 | 60.57 | 42.79 | 51.56 | 55.86 | 47.91 |
Long-Term Debt | 16.16 | 22.99 | 32.09 | 20.2 | 24.7 | - |
Long-Term Leases | 16.68 | 19.25 | 19.28 | 24.17 | 15.32 | - |
Long-Term Unearned Revenue | 10.35 | 10.32 | 12.52 | - | - | - |
Other Long-Term Liabilities | 29.45 | 7.52 | 5.78 | 6.57 | 4.21 | 6.8 |
Total Liabilities | 122.01 | 120.64 | 112.46 | 102.5 | 100.09 | 54.7 |
Common Stock | 29.46 | 16.42 | 16.25 | 12.51 | 12.33 | 10.92 |
Additional Paid-In Capital | 994.11 | 956.71 | 940.68 | 771.19 | 738.48 | 587.49 |
Retained Earnings | -965.92 | -900.88 | -750.22 | -605.64 | -453.66 | -290.24 |
Comprehensive Income & Other | 22.61 | 26.02 | 3.25 | 0.37 | 2.04 | 3.16 |
Total Common Equity | 80.26 | 98.26 | 209.95 | 178.43 | 299.19 | 311.34 |
Shareholders' Equity | 80.26 | 98.26 | 209.95 | 178.43 | 299.19 | 311.34 |
Total Liabilities & Equity | 202.27 | 218.91 | 322.41 | 280.94 | 399.28 | 366.04 |
Total Debt | 47.82 | 58.09 | 59.49 | 58.17 | 45.91 | - |
Net Cash (Debt) | 77.59 | 85.66 | 160.62 | 133.78 | 279.08 | 335.84 |
Net Cash Growth | -11.93% | -46.67% | 20.06% | -52.06% | -16.90% | 273.76% |
Net Cash Per Share | 4.51 | 6.69 | 12.96 | 13.45 | 29.93 | 148.87 |
Filing Date Shares Outstanding | 22.76 | 18.4 | 12.58 | 12.37 | 9.71 | 8.59 |
Total Common Shares Outstanding | 22.73 | 13.02 | 12.57 | 9.83 | 9.69 | 8.59 |
Working Capital | 104.55 | 107.58 | 232.53 | 171.97 | 294.04 | 307.61 |
Book Value Per Share | 3.53 | 7.55 | 16.71 | 18.16 | 30.87 | 36.26 |
Tangible Book Value | 76.94 | 94.7 | 205.8 | 175.36 | 299.19 | 311.34 |
Tangible Book Value Per Share | 3.39 | 7.28 | 16.38 | 17.84 | 30.87 | 36.26 |
Machinery | - | 9.1 | 8.26 | 6.18 | 7.07 | 5.24 |
Construction In Progress | - | 0.76 | 0.21 | 0.3 | 1.85 | 0.24 |
Leasehold Improvements | - | 5.07 | 2.45 | 2.52 | 1.84 | 1.49 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.